# A Study of ART105 in Healthy Adult Participants

> **NCT07748026** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Arnatar Therapeutics, Inc.** · enrollment: 24 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ART105
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07748026
- **Lead sponsor:** Arnatar Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-03
- **Primary completion:** 2027-02-25
- **Final completion:** 2027-02-25
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07748026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07748026, "A Study of ART105 in Healthy Adult Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07748026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*